Hematology NewsNew CAR T-cell therapy eliminates MM and tumor propagating cells without fratricide in lab studyFebruary 26, 2020Multiple Myeloma
Hematology NewsCRISPR-engineered T cells may be safe for cancer, but do they work?February 6, 2020Multiple MyelomaSarcoma & GISTLymphoma & Plasma Cell Disorders
Hematology NewsStart of myeloma therapy may be delayed for women, minoritiesJanuary 21, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsInhibitor appears to strengthen anti-BCMA CAR T cells in myeloma patientsDecember 23, 2019Multiple MyelomaImmunotherapyLymphoma & Plasma Cell DisordersCellular TherapyImmuno-oncology
Hematology NewsD-RVd for frontline myeloma looks robust in GRIFFIN trial updateDecember 17, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsMyeloma patients over age 70 can benefit from auto-HC transplantDecember 7, 2019TransplantationMultiple MyelomaTransplantLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsBispecific CAR T-cells yield high response rate in relapsed/refractory myelomaDecember 7, 2019Multiple MyelomaCellular TherapyImmuno-oncologyImmunotherapyLymphoma & Plasma Cell Disorders
Hematology NewsHigh complete response rate seen with novel CAR-T for myelomaDecember 7, 2019Multiple MyelomaCellular TherapyImmuno-oncologyImmunotherapyLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsASH preview: Key themes include tackling CAR T obstacles, sickle cell advances, VTENovember 26, 2019Cellular TherapyALLMultiple MyelomaLymphoma & Plasma Cell DisordersImmuno-oncologyImmunotherapy
Hematology NewsEarly lenalidomide may delay progression of smoldering myelomaNovember 19, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFoundation launches direct-to-patient registry in multiple myelomaNovember 13, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersPatient & Survivor Care
Multiple Myeloma: A New Treatment Option for Newly Diagnosed, Transplant-Ineligible PatientsNovember 4, 2019Multiple Myeloma
Hematology NewsLevofloxacin prophylaxis improves survival in newly diagnosed myelomaNovember 1, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsSEER analysis reveals medication adherence factors in newly diagnosed myelomaOctober 24, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsWhat is the optimal duration of maintenance in myeloma?October 8, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
